What is BHRT and how do I know if I need it?

Short answer BHRT = bioidentical hormone replacement therapy. It uses hormones that are chemically identical to the ones your body makes (usually estradiol, progesterone, testosterone) to treat symptoms from menopause, perimenopause, premature ovarian insufficiency, or other hormone deficiencies. Whether you “need” it depends on your symptoms, medical risks, test results, and personal goals after a discussion with a clinician.

What BHRT means and how it’s different from other HRT

• Bioidentical: the active hormone molecules are structurally the same as human hormones (e.g., 17β‑estradiol, micronized progesterone).
• Not the same as “natural” or automatically safer: some BHRT products are FDA‑approved prescription drugs (known dose, quality, safety data); many BHRT products are compounded by pharmacies and are not FDA‑approved and may have variable consistency and less safety data.
• Common FDA‑approved bioidentical options: estradiol tablets/patches, micronized progesterone. Compounded BHRT often blends hormones/doses tailored by prescribers.

Who might be a candidate

• People with troublesome menopausal or perimenopausal symptoms (hot flashes, night sweats, sleep/mood changes, vaginal dryness, painful intercourse).
• People with premature ovarian insufficiency or surgically induced menopause.
• Sometimes used for low sexual desire due to hormone deficiency (often in combination with other treatments).
• Not recommended solely for general “anti‑aging” in otherwise healthy people without symptoms.

How clinicians decide whether you need BHRT

• Symptom history and physical exam.
• Review of personal and family medical history (especially breast cancer, thromboembolism, stroke, heart disease, liver disease).
• Baseline testing as appropriate: serum estradiol (sometimes), FSH (to document menopause), TSH, fasting glucose or A1c, lipids, and screening tests (mammogram, pelvic exam) per age and guidelines.
• Discuss risks vs benefits tailored to your health profile and treatment goals.
• If hormone therapy is chosen, pick an appropriate route (vaginal for local symptoms, transdermal/oral for systemic symptoms) and monitor response and side effects.

Benefits and risks (brief)

• Benefits: usually good relief of hot flashes/night sweats, better sleep, improved vaginal dryness and sexual comfort, may prevent bone loss if used appropriately.
• Risks: small increased risk of blood clots and stroke (higher with some oral estrogens and certain progestins), potential effects on breast cancer risk depend on type, dose and duration; other side effects possible. Transdermal estradiol and micronized progesterone may have a lower clot risk than some oral/synthetic hormones, but individual risk varies.

Testing controversies

• Saliva/urine “hormone level” testing used by some compounding clinics is not well validated for guiding systemic dosing. Most clinicians rely on symptoms and, when needed, serum testing.

Alternatives

• Nonhormonal medications for hot flashes (SSRIs/SNRIs, gabapentin, clonidine), local vaginal therapies (lubricants, moisturizers, vaginal DHEA or low‑dose vaginal estrogen), lifestyle measures.

How to get started safely

• See a primary care doctor, OB‑GYN, or menopause specialist. Ask about evidence-based options, the difference between FDA‑approved and compounded products, and a monitoring plan.
• If considering compounded BHRT, use a pharmacy accredited by the Pharmacy Compounding Accreditation Board (PCAB).
• Plan for follow‑up and appropriate screening (mammography, blood pressure, labs).

Specific brands and services (examples and why)

• Prometrium (micronized progesterone): FDA‑approved bioidentical progesterone; widely used because it’s standardized, studied, and has safety data.
• Climara, Vivelle‑Dot, Estraderm (estradiol patches) and Estrace (estradiol tablets): FDA‑approved estradiol products; patches provide steady levels and may carry lower clot risk than some oral estrogens.
• Vagifem (vaginal estradiol tablets) or low‑dose vaginal estradiol creams/ rings: for localized vaginal symptoms with low systemic exposure.
• North American Menopause Society (NAMS): an authoritative professional organization with patient information and clinician guidelines — good resource for evidence-based information.
• Mayo Clinic or Cleveland Clinic menopause/menopause centers: reputable health systems with specialists who follow evidence-based approaches.
• When using a compounding pharmacy: choose a PCAB‑accredited compounding pharmacy (search PCAB-accredited pharmacies online). Example of a frequently used accredited compounding pharmacy: Wedgewood Pharmacy (large, known provider; check current accreditation and reviews).

Practical next steps

1. Make an appointment with your PCP, OB‑GYN, or a menopause specialist. Bring a list of symptoms and your medical/family history.
2. Discuss whether hormone therapy is appropriate, which formulation (vaginal vs systemic), and whether an FDA‑approved product or a compounded product is best for you.
3. If therapy is started, arrange baseline tests and a follow‑up plan for symptom review and safety monitoring.

If you want, tell me your sex assigned at birth, age, main symptoms, relevant medical history (breast cancer, clotting history, heart disease), and whether you prefer local vs systemic treatment — I can give more personalized information about whether BHRT could be appropriate and what options to discuss with your clinician.